NUP210 and primary biliary cholangitis: Additionally, 132 (51.40%) patients were positive for serum antimitochondrial antibody (AMA) or the M2 subtype, and the patients were positive for other PBC-specific antibodies, including anti-sp100 25(9.70%) and anti-gp210 64(24.90%).